Genetic mutations associated with sensitivity to neoadjuvant chemotherapy in metastatic colon cancer: A case report and review of literature
CONCLUSION: NGS can identify precise predictors of response to neoadjuvant chemotherapy, leading to improved outcomes for CRC patients.PMID:34540965 | PMC:PMC8409210 | DOI:10.12998/wjcc.v9.i24.7099
Source: Clinical Colorectal Cancer - Category: Cancer & Oncology Authors: Long Zhao Quan Wang Shi-Dong Zhao Jing Zhou Ke-Wei Jiang Ying-Jiang Ye Shan Wang Zhan-Long Shen Source Type: research
More News: Avastin | Cancer | Cancer & Oncology | Chemotherapy | Colon Cancer | Colorectal Cancer | Eloxatin | Genetics | Liver | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study | Urology & Nephrology